Prognostic significance of marital status in breast cancer survival: A population-based study. – PubMed – NCBI

We know that many factors, including social, environmental and psychological factors play a role in health and disease. Here an interesting study where mortality in breast cancer patients was “associated with marital status, with attention to differences by race/ethnicity, tumor subtype, and neighborhood socioeconomic status “. According to the study “unmarried breast cancer patients have […]

Read More Prognostic significance of marital status in breast cancer survival: A population-based study. – PubMed – NCBI

Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival. – PubMed – NCBI

It has been reported many times-the good old aspirin. But what about the timing and the subtype of colorectal cancer (CRC) that would benefit the most from using aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs)? ” Compared with nonusers, postdiagnostic aspirin-only users had more favorable overall survival and CRC-specific survival , especially among those who […]

Read More Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival. – PubMed – NCBI

Cancer vaccines in colon and rectal cancer over the last decade: lessons learned and future directions. – PubMed – NCBI

“The combination of CRC vaccines with checkpoint inhibitors may unlock the potential of immunotherapy for a much broader range of patients”. Expert Rev Clin Immunol. 2017 Mar;13(3):235-245. doi: 10.1080/1744666X.2016.1226132. Epub 2016 Aug 30. Review More: Cancer vaccines in colon and rectal cancer over the last decade: lessons learned and future directions. – PubMed – NCBI […]

Read More Cancer vaccines in colon and rectal cancer over the last decade: lessons learned and future directions. – PubMed – NCBI

Refractory relapsed Stage IV ovarian… – Hallwang Private Oncology Clinic | Facebook

  Refractory relapsed Stage IV ovarian cancer now 3 years in complete remission under immunotherapy The hope and aim behind cancer immunotherapy is that it induces a durable, long-lasting immune response. One of our patients, Minkara N., was diagnosed with metastatic ovarian cancer in 2012, and after surgery she received chemotherapy – Taxol, Avastin, Gemcitabine […]

Read More Refractory relapsed Stage IV ovarian… – Hallwang Private Oncology Clinic | Facebook

Physician age and outcomes in elderly patients in hospital in the US: observational study | The BMJ

Doctors influence the outcome and treatment of a patient by so many things. Their expertise, their empathy, experience… but what about old age? Naturally, we associate age with experience, and we want to believe that in many cases that is the truth, but a new study reveals that the age of a doctor can also […]

Read More Physician age and outcomes in elderly patients in hospital in the US: observational study | The BMJ

Proof-of-Principle Study of Combination Checkpoint Inhibitor Plus Trastuzumab in HER2-Positive Advanced Breast Cancer – The ASCO Post

Combination of pembrolizumab (Keytruda) plus trastuzumab (Herceptin) as treatment option for patients with trastuzumab-resistant advanced HER2-positive breast cancer!   Quelle: Proof-of-Principle Study of Combination Checkpoint Inhibitor Plus Trastuzumab in HER2-Positive Advanced Breast Cancer – The ASCO Post

Read More Proof-of-Principle Study of Combination Checkpoint Inhibitor Plus Trastuzumab in HER2-Positive Advanced Breast Cancer – The ASCO Post